covid-19 news - They are 99% optimistic about the success of the corona vaccine Chinese scientists working on the covid-19 vaccine claim they are 99% sure it will work. Researchers from the Beijing-based biotechnology research institute Synovac confirmed this to Sky News, a UK broadcaster. The Beijing-based biotech company is building a commercial plant with the goal of supplying 100 million vaccine doses.
The coronavirus vaccine, developed by Synovac, is currently in the second phase of clinical trials. One thousand volunteers are being vaccinated to see if it is safe.
Researchers at Synovac told Sky News they were in preliminary talks with the UK government to begin the third phase of clinical trials.
Sky News Synovac researcher Luo Baishan was asked how optimistic he is about the success of the vaccine. In response, he said, 'It will definitely succeed. 99% sure. '
Last month, Synovac published their findings in the academic journal Science, claiming that their vaccine, called coronavac, had been successfully tested on monkeys. It was able to prevent coronary infections in monkeys.
However, the decline in the number of patients has become a major problem for Synovac in China. Testing the vaccine at the epidemic stage becomes difficult there. As a result, the company is looking for a place where there is more corona infection to complete the third stage of the test.
Helen Young, senior director of investor relations, told Sky News: “We are in talks with a number of European countries and also with the United Kingdom.
As well as continuing research, the company is moving forward with production.
Orange and white packets are already ready at the company’s headquarters in northwest Beijing. Their goal is to start direct production once the vaccine is tested and approved. The company is building a commercial plant for vaccine production in another area of Beijing.
“We would advise, not everyone needs to be vaccinated,” Young said. We are discussing and advising with the governments of different countries about this. We will first look at high-risk populations, including health workers and the elderly. Their mortality rate is higher in Corona. Honestly, the vaccine has to be developed step by step as a lot. '
Of course the vaccine is not going to be expected very soon right now. The third phase will take several months after the completion of the second phase. Once the effectiveness of the vaccine is known, approval will be required. Asked if he is sure of success, Young told Sky News, "It is very difficult to say at this moment. There is uncertainty, but the data says that so far everything is going well.
More than 100 vaccines are being worked on around the world, according to Reuters. About 10 of these vaccines have been tested in humans. The race to bring the world's first vaccine has begun. However, the question arises as to how the vaccine will be distributed and whether the producing countries will prioritize their populations first.
Researchers are working to develop a coronavirus vaccine. Photo: Reuters Chinese scientists working on the vaccine-19 vaccine claim they are 99% sure it will work. Researchers from the Beijing-based biotechnology research institute Synovac confirmed this to Sky News, a UK broadcaster. Sky News is the first British broadcaster to visit the laboratory in Cinevac.
The Beijing-based biotech company is building a commercial plant with the goal of supplying 100 million vaccine doses.
The coronavirus vaccine, developed by Synovac, is currently in the second phase of clinical trials. One thousand volunteers are being vaccinated to see if it is safe.
Researchers at Synovac told Sky News they were in preliminary talks with the UK government to begin the third phase of clinical trials.
Sky News Synovac researcher Luo Baishan was asked how optimistic he is about the success of the vaccine. In response, he said, 'It will definitely succeed. 99% sure. '
Last month, Synovac published their findings in the academic journal Science, claiming that their vaccine, called coronavac, had been successfully tested on monkeys. It was able to prevent coronary infections in monkeys.
However, the decline in the number of patients has become a major problem for Synovac in China. Testing the vaccine at the epidemic stage becomes difficult there. As a result, the company is looking for a place where there is more corona infection to complete the third stage of the test.
Helen Young, senior director of investor relations, told Sky News: “We are in talks with a number of European countries and also with the United Kingdom. It is currently in the early stages of negotiations.
As well as continuing research, the company is moving forward with production.
Orange and white packets are already ready at the company’s headquarters in northwest Beijing. Their goal is to start direct production once the vaccine is tested and approved. The company is building a commercial plant for vaccine production in another area of Beijing.
“We would advise, not everyone needs to be vaccinated,” Young said. We are discussing and advising with the governments of different countries about this. We will first look at high-risk populations, including health workers and the elderly. Their mortality rate is higher in Corona. Honestly, the vaccine has to be developed step by step as a lot. '
Of course the vaccine is not going to be expected very soon right now. The third phase will take several months after the completion of the second phase. Once the effectiveness of the vaccine is known, approval will be required. Asked if he is sure of success, Young told Sky News, "It is very difficult to say at this moment. There is uncertainty, but the data says that so far everything is going well.
More than 100 vaccines are being worked on around the world, according to Reuters. About 10 of these vaccines have been tested in humans. The race to bring the world's first vaccine has begun. However, the question arises as to how the vaccine will be distributed and whether the producing countries will prioritize their populations first.
AstraZeneca, a drug maker working with the University of Oxford in the UK, said that if they could make a vaccine, the UK would be the first to get it.
Chinese President Xi Jinping has promised that after China produces the vaccine, it will be made available to all peoples of the world, although its practical results are unclear. European Union leaders have made similar promises, but US President Donald Trump has not.
"We are already considering not only China, but the whole world," said Yang, a senior official at Sinovac. Not only to conduct an experiment, but also to consider how to solve the problems of countries outside China, including China.
